Board
Variant Bio is a private biotech company that offers a genomic platform for drug development companies to further their research and discover therapeutic methods that can improve patients’ lifespan. LifeSci Search partnered with Variant Bio as they sought to bring aboard a few new team members from multifaceted backgrounds to maintain their growing network of…
Read More
Pixium Vision, publicly listed on Paris Euronext with a market cap of $30m, is engaged in the business of developing implantable medical devices to treat blindness resulting from the degeneration of retinal photoreceptor cells. They harness rapid advances in visual processing, micro-electronics, opto-electronics, neurobiology, and intelligent software algorithms to develop Bionic Vision Systems. These Bionic Vision Systems…
Read More
Moleculin Biotech, Inc. is a public clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The company’s lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity. With a need to add…
Read More
SpineThera designs and develops sustained-release, injectable drugs to meet the unique safety requirements for administration in and near the spine. They aim to offer patients and physicians new treatment options that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs. SpineThera was seeking two new board members…
Read More
Known as “the crop health company,” Enko Chem designs safe and sustainable solutions for farmers’ biggest crop threats today, from pest resistance to new diseases. Enko Chem are applying the latest drug discovery and development approaches from the pharma industry to agricultural challenges. The next phase was to build and implement an Artificial Intelligence platform.…
Read More